newsfilter
← Latest News
Business Wire·

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease,